Inhibition of <scp>DDR</scp> 1‐ <scp>BCR</scp> signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
2018 · EMBO Molecular Medicine · 109 citations
https://doi.org/10.15252/emmm.201707918
A
Audrey Sirvent
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
66
Papers
2.1K
Citations
21
h-index
27
i10-index
Audrey Sirvent is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Protein Kinase Regulation and GTPase Signaling & Colorectal Cancer Treatments and Studies & Drug Transport and Resistance Mechanisms. The author has an h-index of 21, co-authored 57 publications.
ORCID: 0000-0003-4555-6312Papers by this author
worksAnalysis of SRC Oncogenic Signaling in Colorectal Cancer by Stable Isotope Labeling with Heavy Amino Acids in Mouse Xenografts
2012 · Molecular & Cellular Proteomics · 32 citations
https://doi.org/10.1074/mcp.m112.018168
Regulation of Src tumor activity by its N-terminal intrinsically disordered region
2022 · Oncogene · 19 citations
https://doi.org/10.1038/s41388-021-02092-x
Lipid-driven Src self-association modulates its transformation capacity
2025 · Life Science Alliance · 1 citations
https://doi.org/10.26508/lsa.202403019
SLAP controls mTORC2 integrity via UBE3C-mediated non-degradative mLST8 ubiquitination to suppress colorectal tumorigenesis
2025 · Cell Death and Differentiation · 1 citations
https://doi.org/10.1038/s41418-025-01633-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat